Cookies on this website

We use cookies to ensure that we give you the best experience on our website. If you click 'Accept all cookies' we'll assume that you are happy to receive all cookies and you won't see this message again. If you click 'Reject all non-essential cookies' only necessary cookies providing core functionality such as security, network management, and accessibility will be enabled. Click 'Find out more' for information on how to change your cookie settings.

This year marks the 200th anniversary of the publication of the first codified description of the condition that we now know as Parkinson's disease.

Associate Professor Chrystalina Antoniades from the Nuffield Department of Clinical Neurosicences, and Dr Patrick Lewis from the University of Reading have co-organised the following events to mark the anniversary, together with the Oxford branch of Parkinson's UK.

Exhibition, 11-19 September

The author of the publication describing the condition, James Parkinson, called the disease the Shaking Palsy. Parkinson's talents, however, stretched well beyond neurology. He was a political agitator, general science writer and an influential geologist - all aspects of his work that are showcased in an exhibition from the collections of the Bodleian Library.

Conference, 18 September

This conference for people with Parkinson's, families, friends and healthcare professionals is devised and presented by Parkinson's UK Oxford Branch in collaboration with the University of Oxford's Nuffield Department of Clinical Neurosciences and other leading organisations.

Sessions cover:

  • Progress in research and therapy
  • Sharing best practice
  • Achieving best quality of life

Read more about the conference.

Similar stories

Repurposed drug could help patients with motor neuron disease

A drug typically used to treat enlarged prostates and high blood pressure has shown promise as a potential new therapy for motor neuron disease (MND), according to a new study.

Finding out more about Parkinson’s by monitoring symptoms at home

Professor Chrystalina Antoniades explains how the COVID pandemic accelerated an innovation in one research project into Parkinson's Disease.

Insights into the molecular pathways of progressive multiple sclerosis

Text by Ian Fyfe for 'Nature Reviews Neurology'

Discovery of gene involved in chronic pain creates new treatment target

Our researchers have discovered a gene that regulates pain sensitisation by amplifying pain signals within the spinal cord. This is helping them to understand an important mechanism underlying chronic pain in humans, and provides a new treatment target.

Lymph nodes reveal more about mechanisms of autoimmunity

Two recent papers show that studying lymph nodes reveals details of the mechanisms of autoimmunity.

Multiple heart-related conditions linked to triple dementia risk, regardless of genetics

Having multiple conditions that affect the heart is linked to a greater risk of dementia than having high genetic risk, according to a large-scale new study.